*By Conor White*
Despite sci-fi's habit of making technology the enemy, DJ/entrepreneur Steve Aoki doesn't think machines are necessarily the villains. That's why he's written a new comic book, "Neon Future," to cast A.I. in a different, less ominous light.
"In most sci-fi, in most comic book stories, technology is the problem...or is the evil machine," Aoki told Cheddar this weekend at New York Comic Con. "In this story, we tell something different."
"I really feel like we can use A.I. to the point where we eventually will become cyborgs," he added.
Aoki's comic book tells of a near-future when dictators have stripped citizens of their technology. A hero emerges, showing the world that humans and tech can, in fact, live in harmony.
"I want to see a future where we keep finding ways and avenues to use A.I., to use technology, so we can keep growing," said Aoki, who in addition to his DJ gig owns both his own clothing line and a chain of pizza restaurants. He reportedly has earned $28 million so far this year.
Tom Bilyeu, co-founder of Impact Theory, the studio publishing the comic book, agreed with Aoki.
"Science-fiction authors have a moral obligation to paint a picture of a future worth building," he told Cheddar. "That's literally what we're trying to do."
"Neon Future" takes place just 30 years in the future, a conscious decision by its creators.
"We wanted the world to be entirely too recognizable, so that the threat that's happening becomes really real," Bilyeu said.
"What we wanted to do was start in a world that's dystopian and then explore: How do you get out of that?"
For full interview [click here](https://cheddar.com/videos/steve-aokis-future).
On Monday, football fans were stunned when Buffalo Bills safety Damar Hamlin collapsed and suffered cardiac arrest. Cheddar News explains the condition and the steps to take if you witness an incident.
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
Join Cheddar News as we break down the top headlines this morning including updates on the Jan. 6 hears, the PGA suspension of 17 of the world's best golfers, and NASA's plans to study UFOs.
Rick Pauls, President & CEO OF DiaMedica Therapeutics, joins Cheddar Innovates to discuss a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients.
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
